
Siemens plans to transfer its stake in a nuclear magnetic resonance equipment manufacturer valued at 15 billion euros to investors
Siemens AG transferred 30% of its stake in Siemens Healthineers AG to its shareholders, allowing it to reduce its holdings in the medical technology business and focus on software operations. This move will leave Siemens with a 37% stake in the former subsidiary, with the goal of reducing this stake to a financial asset in the medium term. This direct spin-off still requires approval from regulators and shareholders, and Siemens will provide more details next year
